Advertising requirements
Compiled text through Jul 31, 2022
Register checked through Jul 29, 2026
Later Register activity found — review the notice before relying on the compiled text.
Dates and status
- Compiling agency
- Executive Department
- Text status
- Source receipt
- Compiled text through
- Jul 31, 2022
- Register checked through
- July 29, 2026/Vol. XLVIII, Issue 30 (2026-07-29)
- Activity status
- Later Register activity found — review the notice before relying on the compiled text.
- Latest notice
- OCM-32-23-00031-EP · Emergency and proposed rule · Jul 27, 2023
- Source snapshot
- Jun 6, 2026
(a)An advertisement for a cannabinoid hemp product, cannabinoid hemp processor or cannabinoid hemp retailer shall not:
(1)make any false or misleading claims or statements;
(2)contain claims that cannabinoid hemp or a cannabinoid hemp product can, or is intended to, diagnose, cure, mitigate, treat, or prevent disease;
(3)lead a reasonable person to believe that a cannabinoid hemp product is cannabis, marihuana, medical cannabis, or medical marihuana, or that a licensee is authorized to sell or dispense cannabis, marihuana, medical cannabis, or medical marihuana, as those terms are defined in Section 3 of the Cannabis Law and Article 33 of the Public Health Law;
(4)have the purpose or effect of targeting or appealing to anyone under 21 years of age for inhalable cannabinoid hemp products or flower product. The use of images of children or minors consuming the product and the use of words, a design or brand that resembles a product that is commonly associated with children or minors or marketed to children or minors, is prohibited.